These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28520410)

  • 21. Targeting aspartate aminotransferase in breast cancer.
    Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
    Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
    Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
    Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers.
    Guo Z; He B; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Int J Pharm; 2015 Sep; 493(1-2):380-9. PubMed ID: 26004003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
    Hwang DW; Bahng N; Ito K; Ha S; Kim MY; Lee E; Suga H; Lee DS
    Cancer Lett; 2017 Jan; 385():144-149. PubMed ID: 27810404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
    Moura V; Lacerda M; Figueiredo P; Corvo ML; Cruz ME; Soares R; de Lima MC; Simões S; Moreira JN
    Breast Cancer Res Treat; 2012 May; 133(1):61-73. PubMed ID: 21805188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation.
    Garg SM; Paiva IM; Vakili MR; Soudy R; Agopsowicz K; Soleimani AH; Hitt M; Kaur K; Lavasanifar A
    Biomaterials; 2017 Nov; 144():17-29. PubMed ID: 28818703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour targeting of lipid nanocapsules grafted with cRGD peptides.
    Hirsjärvi S; Belloche C; Hindré F; Garcion E; Benoit JP
    Eur J Pharm Biopharm; 2014 May; 87(1):152-9. PubMed ID: 24361535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Osada T; Kaneko K; Gwin WR; Morse MA; Hobeika A; Pogue BW; Hartman ZC; Hughes PF; Haystead T; Lyerly HK
    Clin Cancer Res; 2017 Dec; 23(24):7531-7542. PubMed ID: 28993342
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer.
    Liu S; He Z; Hsieh WY; Kim YS; Jiang Y
    Bioconjug Chem; 2006; 17(6):1499-507. PubMed ID: 17105229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
    Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
    Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiopharmacokinetic and dosimetric parameters of 188Re-lanreotide in athymic mice with induced human cancer tumors.
    Molina-Trinidad EM; de Murphy CA; Ferro-Flores G; Murphy-Stack E; Jung-Cook H
    Int J Pharm; 2006 Mar; 310(1-2):125-30. PubMed ID: 16423478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
    Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
    Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
    Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
    Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide modified polymeric micelles specific for breast cancer cells.
    Mathews AS; Ahmed S; Shahin M; Lavasanifar A; Kaur K
    Bioconjug Chem; 2013 Apr; 24(4):560-70. PubMed ID: 23514428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.